MediVet Biologics is pleased to announce the addition of Merritt Veterinary Supplies, Inc. as a preferred distribution partner for MediVet Biologics products and services.

An official launch of the product lines will be held at three regional locations providing access to Merritt customers for live continuing education on the range of cutting edge treatment options in which MediVet Biologics provides to the Veterinary community.

Jeremy Delk, CEO with MediVet Biologics, welcomed the team at Merritt Veterinary Supplies, Inc.:

“Our entire organization is excited to launch our product line with Merritt. The core values of Merritt’s business and commitment to customer service matched our own mission in which we bring products and services to the marketplace. The continued goal of our organization is to assist millions of animals around the world with medical treatment options based in science and affordability. Our distribution partners are extremely important in assisting us achieve that mission as well as allowing us expansion of our product pipeline into the future with new offerings. We look forward to supporting Merritt customers.”

Jeff Morrison Business Development Manager of Merritt said, “Merritt is certainly excited to partner with MediVet Biologics to offer this technology and patient life improvement to our customers. Our sales team excels in developing strategies to implement new science into our industry to better service veterinarians and their clients.”

July Continuing Education Events:

July 14th Merritt-MediVet Biologics Dinner Coral Gables, Florida

July 15th Merritt-MediVet Biologics Dinner Birmingham, Alabama

July 16th Merritt-MediVet Biologics Dinner Charlotte, North Carolina

If would like to RSVP or inquire about event location, times and CE please contact: Sarah Bernard at Sarah@medivetbiologics.com

About MediVet Biologics:

MediVet Biologics is a leader in Veterinary cellular medicine and the first company to offer in-clinic adipose derived stem cell treatments to Veterinarian practitioners.

Since 2010, the Central Kentucky based company has built a portfolio of thousands of progressive Veterinarians across the globe serving over 10,000 animal patients treated to date. Since 2010 MediVet Biologics has expanded products and services to include tissue engineering products and services, Platelet Rich Plasma and currently in trials for a new canine cancer vaccine.

The company’s mission is to provide novel treatment options based in science at affordable prices that reach the brick and mortar general practice to assist millions of animals needlessly suffering in pain.

http://www.medivetbiologics.com

https://www.merrittvet.com/about-mvs.aspx







More Medicine Press Releases